City of Santa Fe Defective Breast Mesh & Breast Implant Injury Attorneys, Attorney911 (The Manginello Law Firm, PLLC) for BIA-ALCL, BIA-SCC and Reconstruction Device Failures: Ralph Manginello with 27+ Years of Federal Trial Experience and Lupe Peña, Former Insurance Defense Attorney Conducting Consultations in Fluent Spanish, We Litigate Allergan BIOCELL (Recalled July 2019, MDL 2921 before Judge Martinotti, Bellwether trial October 19, 2026), Mentor MemoryGel, Sientra OPUS, AlloDerm and Strattice ADM, GalaFLEX P4HB Scaffolds and Polypropylene Surgical Mesh, Commanding BIA-ALCL CD30+/ALK- Pathology and 21 CFR Parts 803, 807 and 814 Regulatory Frameworks Under New Mexico’s 3-Year Statute of Limitations and Discovery Rule (N.M. Stat. Ann. § 37-1-8), $50M+ Recovered for Families and Active Lead Counsel in the $10M Bermudez v. Pi Kappa Phi Litigation — Free 24/7 Consultation, No Fee Unless We Recover Compensation for You, Hablamos Español, 1-888-ATTY-911
Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of Santa Fe: The Complete Guide for Women and Families For a woman in City of Santa Fe, the decision to undergo breast reconstruction after a mastectomy or to pursue a mastopexy (breast lift) or augmentation is a deeply personal choice often rooted in the desire to feel whole again or to restore confidence. Many residents of City of Santa Fe travel to the renowned Texas Medical Center or local specialist hubs like UTMB Health in nearby League City or Galveston to receive what they believe is the highest standard of surgical care. However, for many women in City of Santa Fe, that journey toward healing has been interrupted by the failure of surgical devices—acellular dermal matrices (ADMs), bioabsorbable scaffolds, and synthetic meshes—that often were never specifically approved for use in the breast. At Attorney911 (The Manginello Law Firm, PLLC), we recognize that a diagnosis of a device-related complication like red breast syndrome, chronic infection, or the devastating news of a breast implant-associated cancer (BIA-ALCL or BIA-SCC) can feel like a betrayal by both the medical device industry and the regulatory systems meant to protect you. We…